White paper: The next step to automating clinical trials

Document
Temperature management is critical when it comes to ensuring patient safety in clinical development, but we continue to use legacy point solutions that require heavy manual processes and duplication of data.
However, there are new solutions that digitize manual processes, resulting in reduced site burden, timely kit level data for study teams, and ensuring safe delivery right to the patient.
What is on this page?
Click to jump to a specific section below.
Automating Clinical Trials
“You can say that if you meet all the needs of clinical you would meet all the needs of commercial, but you can’t say the inverse - you can’t say that if you meet all commercial needs, you’d satisfy all the regulatory requirements of a clinical setting.”
So argues Evan Hahn, VP of TSS North America, making the point that perhaps we’re guilty of offering similar solutions for both clinical and commercial distribution streams when their requirements - although they share certain elements - are ultimately different.
Download this white paper where Evan Hahn, VP TSS North America, Tobias Holmer CPO at TSS, and Cat Hall, VP of Clinical Innovation and Quality at Endpoint Clinical discuss how automating Clinical Trials and tight technical integrations are key to increasing the rate of successful outcomes of clinical trials, while also speeding up the whole clinical process.
You may also be interested in

Join us at Clinical Trial Supply Europe 2024 in Barcelona
Are you in pursuit of optimizing the temperature management of your clinical trials supply chain? Get inspired by experts from the field, and learn from their experiences.
Read moreDownload Whitepaper
LogiPharma Lyon 2024
The Future of Temperature Monitoring: How to lower the CO2 footprint with a Circular Supply Solution
Read moreDownload Whitepaper.avif)
On-demand webinar: A unified approach to clinical supply temperature management
Automation of temperature excursion handling and data flow to streamline site activities
Read moreDownload WhitepaperYou may also be interested in

What Do EMA’s Updated Shortage Prevention Guidelines Mean for Pharmaceutical Leaders?
The European Medicines Agency has updated its guidance and template for Shortage Prevention Plans. For pharmaceutical leaders, the development is more than a regulatory planning exercise. It is an invitation to examine whether their organizations can identify supply vulnerabilities early and respond before an issue affects medicine availability.
Read more
On-demand webinar: Introducing BLE technology for temperature monitoring
Get introduced to the solution tailored to GxP critical shipments – BLE technology for temperature monitoring
Read more
